Novartis AG vs Roblox Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Roblox Corp trades at $52.5 (market cap $38.13B). The key difference: Novartis AG is far larger — about 7.6× Roblox Corp's market cap, and Novartis AG pays a 3.17% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| NVS | RBLX | |
|---|---|---|
Market Cap | $290.25B | $38.13B |
Sector | Health | Media |
52-Week High | $168.62 | $141.56 |
52-Week Low | $113.50 | $41.30 |
Enterprise Value | $330.27B | $36.71B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →